Literature DB >> 7478241

Induction of nitric oxide synthase activity in rodent brain following middle cerebral artery occlusion.

T Yoshida1, C Waeber, Z Huang, M A Moskowitz.   

Abstract

The conversion of L-[3H]arginine to L-[3H]citrulline in the absence of calcium can be used to assay selectively the activity of inducible nitric oxide synthase (NOS) in rat spleen homogenates 6 h after lipopolysaccharide administration. Using similar assay conditions, changes in inducible NOS activity were measured within ischemic brain tissue between 2 h and 7 days following permanent middle cerebral artery (MCA) occlusion in Sprague-Dawley rats and SV-129 mice. Total (constitutive and inducible) NOS activity was measured in the presence of 0.5 mM CaCl2. Whereas total NOS activity in rat decreased dramatically to 16% and 6% of baseline 6 and 12 h after MCA occlusion, inducible NOS activity remained undetectable before 2 days after occlusion, became maximal at 3 days, and decreased to less than 10% of maximal iNOS activity at 7 days. In the mouse, total NOS activity decreased after MCA occlusion but inducible NOS activity was undetectable from 2 h to 4 days after occlusion. Sustained NO production by inducible NOS activity does not contribute to ischemic injury within 24 h after MCA occlusion, but may contribute to infarct maturation 2-4 days after ischemia in some but not all species.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7478241     DOI: 10.1016/0304-3940(95)11752-i

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Fingolimod provides long-term protection in rodent models of cerebral ischemia.

Authors:  Ying Wei; Muge Yemisci; Hyung-Hwan Kim; Lai Ming Yung; Hwa Kyoung Shin; Seo-Kyoung Hwang; Shuzhen Guo; Tao Qin; Nafiseh Alsharif; Volker Brinkmann; James K Liao; Eng H Lo; Christian Waeber
Journal:  Ann Neurol       Date:  2010-11-12       Impact factor: 10.422

2.  Caspases determine the vulnerability of oligodendrocytes in the ischemic brain.

Authors:  M Shibata; S Hisahara; H Hara; T Yamawaki; Y Fukuuchi; J Yuan; H Okano; M Miura
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

3.  Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neural damage.

Authors:  M J Eliasson; Z Huang; R J Ferrante; M Sasamata; M E Molliver; S H Snyder; M A Moskowitz
Journal:  J Neurosci       Date:  1999-07-15       Impact factor: 6.167

4.  Delayed treatment with carboxy-PTIO permits a 4-h therapeutic window of opportunity and prevents against ischemia-induced energy depletion following permanent focal cerebral ischemia in mice.

Authors:  E-Jian Lee; Yu-Chang Hung; Hung-Yi Chen; Tian-Shung Wu; Tsung-Ying Chen
Journal:  Neurochem Res       Date:  2008-12-14       Impact factor: 3.996

5.  Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice.

Authors:  Sébastien Lenglet; Fabrizio Montecucco; Adam Denes; Graham Coutts; Emmanuel Pinteaux; François Mach; Karl Schaller; Yvan Gasche; Jean-Christophe Copin
Journal:  J Cereb Blood Flow Metab       Date:  2014-01-29       Impact factor: 6.200

Review 6.  Expression of nitric oxide synthase-2 in glia associated with CNS pathology.

Authors:  A K Loihl; S Murphy
Journal:  Prog Brain Res       Date:  1998       Impact factor: 2.453

Review 7.  Nitric Oxide Synthase Inhibitors as Antidepressants.

Authors:  Gregers Wegener; Vallo Volke
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-20

Review 8.  Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma.

Authors:  Antonio Inserra; Claudio Alberto Mastronardi; Geraint Rogers; Julio Licinio; Ma-Li Wong
Journal:  Mol Neurobiol       Date:  2018-10-10       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.